Loading
AT
Antibe Therapeutics Inc. Stock: price and insider trades · Canada
Antibe Therapeutics Inc.: what insiders have been doing
Antibe Therapeutics Inc. is a listed company. Filings by its managers are published through SEDI. Nothing new has been filed by managers of Antibe Therapeutics Inc. in twelve months, the latest record being from 7 March 2024.
The full history, which starts in 2016, counts 65 purchases against 48 sales.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
268
Thresholds
n/a
Buy Volume
€651,642
65 ops. · all time
Sell Volume
€4M
48 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 7 March 2024
Declarations268 total
15,000 shares@ CA$0.524.9% of flowCommon SharesTSXSEDI:4273321
Canonical exit: 5 Jun 2024 (T+90)
20,000 shares@ CA$0.500.2% of flowCommon SharesTSXSEDI:4272900
Canonical exit: 5 Jun 2024 (T+90)
24,000 shares@ CA$0.4011.8% of flowCommon SharesTSXSEDI:4271813
Canonical exit: 4 Jun 2024 (T+90)
49,880 shares@ CA$0.9414.7% of flowCommon SharesTSXSEDI:4260367
28,000 shares@ CA$0.9433.0% of flowCommon SharesTSXSEDI:4260373
20,784 shares@ CA$1.076.9% of flowCommon SharesTSXSEDI:4243525
11,666 shares@ CA$1.0764.0% of flowCommon SharesTSXSEDI:4243537
40,000 shares@ CA$1.07100.0% of flowCommon SharesTSXSEDI:4243531
13,334 shares@ CA$1.074.2% of flowCommon SharesTSXSEDI:4243533
11,666 shares@ CA$1.0715.5% of flowCommon SharesTSXSEDI:4243527
11,666 shares@ CA$1.0764.0% of flowCommon SharesTSXSEDI:4243535
13,334 shares@ CA$1.073.0% of flowCommon SharesTSXSEDI:4243529
3,333 shares@ CA$1.040.9% of flowCommon SharesTSXSEDI:4211000
1,667 shares@ CA$1.040.3% of flowCommon SharesTSXSEDI:4211004
1,667 shares@ CA$1.047.7% of flowCommon SharesTSXSEDI:4211010
1,667 shares@ CA$1.047.7% of flowCommon SharesTSXSEDI:4211012
1,667 shares@ CA$1.040.4% of flowCommon SharesTSXSEDI:4211008
1,667 shares@ CA$1.045.9% of flowCommon SharesTSXSEDI:4211002
5,000 shares@ CA$1.043.5% of flowCommon SharesTSXSEDI:4211014
1,667 shares@ CA$1.042.4% of flowCommon SharesTSXSEDI:4211006
3,333 shares@ CA$0.5437.9% of flowCommon SharesTSXSEDI:4122859
16,666 shares@ CA$0.549.9% of flowCommon SharesTSXSEDI:4122855
11,667 shares@ CA$0.598.7% of flowCommon SharesTSXSEDI:4063051
20,783 shares@ CA$0.593.9% of flowCommon SharesTSXSEDI:4063049
11,667 shares@ CA$0.5936.0% of flowCommon SharesTSXSEDI:4063059
25 of 268 declarations
About Antibe Therapeutics Inc.
Antibe Therapeutics Inc. is a biopharmaceutical company focused on developing treatments for pain and inflammation. It is listed on the XTSE market.
